The Sum of Fears in Cancer Patients Inside the Context of the COVID-19

Bandinelli, Lucas Poitevin; Ornell, Felipe; Diemen, Lísia von; Kessler, Félix Henrique Paim

doi:10.3389/fpsyt.2021.557834

Cited by 26 publications

(28 citation statements)

References 94 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, it is necessary to consider that access to information and communication technologies (ICT) and the internet network is heterogeneous in Brazil, and many socially vulnerable individuals do not have access to teleconsultations. It is relevant to mention that teleconsultations can be especially difficult for patients with disabilities, ophthalmological problems, oncologic patients, the elderly, and psychiatric patients, especially with acute symptoms, including those experiencing psychotic symptoms [ [45] , [46] , [47] , [48] , [49] ]. Home care could also be an alternative to provide some support to patients with high demand, and our findings indicate an increase in this health service [ 19 ].…”

Section: Discussionmentioning

confidence: 99%

The next pandemic: impact of COVID-19 in mental healthcare assistance in a nationwide epidemiological study

Ornell

Borelli

Benzano

et al. 2021

The Lancet Regional Health - Americas

Self Cite

View full text Add to dashboard Cite

Background Studies have reported the worsening of psychiatric symptoms during the COVID-19 pandemic. However, few studies have evaluated the impact on the access to mental health services during COVID-19. Our aim was to analyze temporal trends and prediction of appointments held in Brazil's public health system, to compare the observed and expected number of mental healthcare appointments during the COVID-19 pandemics. Methods An ecological time-series study was performed, analyzing mental health appointments before and during the pandemic (from 2016 and 2020) from the Brazilian governmental database. The structural break in the data series was assessed using the Chow test, with the break considered in March 2020. Bayesian structural time-series models were used to estimate current average appointments and the predicted expectation if there was no pandemic. Findings Compared to the expected, between March and August 2020 about 28% less outpatient appointments in mental health were observed, totaling 471,448 individuals with suspended assistance. Group appointments and psychiatric hospitalizations were also severely impacted by the pandemic (decreased of 68% and 33%, respectively). On the other hand, mental health emergency consultations and home care increased during this period (36% and 52%, respectively). Interpretation Our findings demonstrate a dramatic change in mental health assistance during the COVID-19 pandemic, which corroborates a recent WHO survey. This phenomenon can aggravate the mental health crisis and generate a parallel pandemic that may last for a longer time than the COVID-19 pandemic. Funding This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001.

show abstract

Section: Discussionmentioning

confidence: 99%

The next pandemic: impact of COVID-19 in mental healthcare assistance in a nationwide epidemiological study

Ornell

Borelli

Benzano

et al. 2021

The Lancet Regional Health - Americas

Self Cite

View full text Add to dashboard Cite

show abstract

“…While diagnostic delays will clearly have an impact on the likelihood of successfully treating a particular tumor, a later diagnosis also causes significant mental and emotional stress [ 9 ]. This likely to have been particularly magnified due to the nature of the pandemic, with physical distancing contributing to the distress caused by removal from personal support systems such as family and friends [ 24 ].…”

Section: Impact On the Investigation Of Patients With Suspected Cancermentioning

confidence: 99%

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials

Ali

Riches

2021

Cancers

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic has caused considerable global disruption to clinical practice. This article will review the impact that the pandemic has had on oncology clinical trials. It will assess the effect of the COVID-19 situation on the initial presentation and investigation of patients with suspected cancer. It will also review the impact of the pandemic on the subsequent management of cancer patients, and how clinical trial approval, recruitment, and conduct were affected during the pandemic. An intriguing aspect of the pandemic is that clinical trials investigating treatments for COVID-19 and vaccinations against the causative virus, SARS-CoV-2, have been approved and conducted at an unprecedented speed. In light of this, this review will also discuss the potential that this enhanced regulatory environment could have on the running of oncology clinical trials in the future.

show abstract

“…Whilst diagnostic delays will clearly have an impact on the likelihood of successfully treating a particular tumor, a later diagnosis also causes significant mental and emotional stress [5]. This likely to have been particularly magnified due to the nature of the pandemic, with physical distancing contributing to the distress caused by removal from personal support systems such as family and friends [20].…”

Section: Impact On the Investigation Of Patients With Suspected Cancermentioning

confidence: 99%

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials

Ali¹,

Riches²

2021

Preprint

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic has caused considerable global disruption to clinical practice. This article will review the impact that the pandemic has had on oncology clinical trials. It will assess the effect of the COVID-19 situation on the initial presentation and investigation of patients with suspected cancer. It will also discuss the impact of the pandemic on the subsequent management of cancer patients and how clinical trial approval, recruitment and conduct were affected during the pandemic. An intriguing aspect of the pandemic is that clinical trials investigating treatments for COVID-19 and vaccinations against the causative virus, SARS-CoV-2, have been approved and conducted at unprecedented speed. In light of this, this re-view will also discuss the potential that this enhanced regulatory environment could have on the running of oncology clinical trials in the future.

show abstract

The Sum of Fears in Cancer Patients Inside the Context of the COVID-19

Cited by 26 publications

References 94 publications

The next pandemic: impact of COVID-19 in mental healthcare assistance in a nationwide epidemiological study

The next pandemic: impact of COVID-19 in mental healthcare assistance in a nationwide epidemiological study

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials

Contact Info

Product

Resources

About